ISPE Publishes Guide for Process Gases - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

ISPE Publishes Guide for Process Gases


ePT--the Electronic Newsletter of Pharmaceutical Technology

Last week, the International Society for Pharmaceutical Engineering (ISPE) published a guidance document titled ISPE Good Practice Guide: Process Gases. The guide defines current best practices in pharmaceutical manufacturing applications for handling gases that come into direct contact with the biopharmaceutical and pharmaceutical process steams (e.g., nitrogen, oxygen, argon, carbon dioxide, and compressed air).

ISPE Good Practice Guide: Process Gases describes cost-effective engineering approaches for establishing a process-gas system for a manufacturing facility in a timely manner. The guide is meant to help users avoid increasing facility installation and operation costs. It also examines issues crucial to product quality for the production of biopharmaceutical and pharmaceutical drug substances and drug products.

The bulk of the guide is dedicated to the process of designing, constructing, commissioning, and qualifying a process-gas system that is regulated by international regulatory authorities, including FDA and EMA. One section provides advice about developing user-requirements documentation, including how to define user requirements, equipment-performance requirements, and maintenance requirements, for a process-gas system. Other sections describe design options for process-gas generation systems, compressed-air systems, distribution systems, and control and monitoring systems. Finally, the guide explains how to assess the risk in process-gas systems, how to establish the systems’ final design, and how to shape maintenance and operation protocols for the systems.

The guide is intended to provide a common language and understanding of gas systems to the pharmaceutical-manufacturing and engineering communities. It addresses the key concepts of product and process understanding, a life-cycle approach within a quality-management system, scalable life-cycle activities, science-based quality risk management, and using supplier involvement. The guide promotes a science- and risk-based approach to process-gas systems, and is intended to follow the principles of ICH Q9 and ASTM-E2500.

ISPE is an international, not-for-profit association of pharmaceutical science and manufacturing professionals who collaborate with global regulatory agencies and industry leaders. The organization develops guides and solutions for good manufacturing practices that are intended to improve the industry’s operations.

ISPE Good Practice Guide: Process Gases
www.ISPE.org/ispegpg/ProcessGases

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
18%
To all process for new products only
13%
To select process for new products only
22%
To select processes for both new and legacy products
22%
Do not use QbD
24%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Inadequate Access to Medicines Puts EU at Risk
FDA Offers Insight on QbD for Modified-Release Products
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
FindPharma Custom Search
Source: ePT--the Electronic Newsletter of Pharmaceutical Technology,
Click here